Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

FDA Calls Bay Area Global Blood Therapeutics' Sickle Cell Drug a Breakthrough

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

The BTD decision for voxelotor was based on clinical data submitted from a trio of studies. Source: BioSpace

Continue ReadingFDA Calls Bay Area Global Blood Therapeutics' Sickle Cell Drug a Breakthrough

REGENXBIO Banks on Strong Gene Therapy Pipeline and Potential Partnerships

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

Gene therapy treatment is a high risk, high reward venture, but the promises of a therapy developed through these programs could be life-changing for patients. Source: BioSpace

Continue ReadingREGENXBIO Banks on Strong Gene Therapy Pipeline and Potential Partnerships

Jobs Lost as Cellectar Biosciences Shutters Manufacturing Operations

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

Cellectar Biosciences is closing its manufacturing operations and contracting them out. Source: BioSpace

Continue ReadingJobs Lost as Cellectar Biosciences Shutters Manufacturing Operations

Bridging Clinical Research & Clinical Health Care: How to Improve Patient Centricity

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

For multiple perspectives on addressing this challenge, three respected individuals involved with the effort to bridge clinical research and clinical health care share their views. Source: BioSpace

Continue ReadingBridging Clinical Research & Clinical Health Care: How to Improve Patient Centricity

SoCal's Evolus Files for $75M IPO

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

Cantor Fitzgerald & Co. and Mizuho Securities USA LLC are acting as joint book-running managers for the offering. Source: BioSpace

Continue ReadingSoCal's Evolus Files for $75M IPO

Axovant's Nightmare Week Continues After CEO Admits Numbers Were Even Worse Than Reported Yesterday

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

Vivek Ramaswamy's Axovant has egg on its face after it was forced to own up to the fact it misreported mid-stage data on a drug it hoped to take into…

Continue ReadingAxovant's Nightmare Week Continues After CEO Admits Numbers Were Even Worse Than Reported Yesterday

Germany's Novaliq Sets Up U.S. Subsidiary in Cambridge, Massachusetts

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

As an emerging leader in the field of ophthalmology, Novaliq is currently pursuing two late-stage clinical trials in the United States. Source: BioSpace

Continue ReadingGermany's Novaliq Sets Up U.S. Subsidiary in Cambridge, Massachusetts

Johnson & Johnson Dives Into 2018 With 15 New Deals

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

The latest collaborations bring the total number of strategic transactions executed by J&J Innovation to more than 350 since its establishment in 2012. Source: BioSpace

Continue ReadingJohnson & Johnson Dives Into 2018 With 15 New Deals

Pfizer to Cut 300 Jobs as It Ends Alzheimer's, Parkinson's Quest

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

About 200 of the job cuts will be in Massachusetts, the remaining in Connecticut. Source: BioSpace

Continue ReadingPfizer to Cut 300 Jobs as It Ends Alzheimer's, Parkinson's Quest

New Jersey's Leading Pharma, LLC Scores $40M

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

The transaction was led by Signet Healthcare Partners in addition to Crestline Investors with other investors comprised of Cane Investment Partners and existing Leading Pharma members. Source: BioSpace

Continue ReadingNew Jersey's Leading Pharma, LLC Scores $40M
  • Go to the previous page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.